End of Summer Pool Party: CFTC Approves Final Rule Amending 4.7 Regulatory Relief for CPOs and CTAs

On 12 September 2024, the Commodity Futures Trading Commission (CFTC) published a Final Rule impacting registered commodity pool operators (CPOs) and commodity trading advisors (CTAs) relying on the regulatory relief provided under CFTC Regulation 4.7. “Registration light,” as Regulation 4.7 is sometimes known, provides reduced disclosure, reporting and recordkeeping obligations for CPOs and CTAs that limit sales activities to “qualified eligible persons” (QEPs).

The Final Rule amends Regulation 4.7 by:

  • Updating the QEP definition by increasing the financial thresholds in the “Portfolio Requirement” to account for inflation; and
  • Codifying certain CFTC no-action letters allowing CPOs of Funds of Funds to opt to deliver monthly account statements within 45 days of month-end.

For most asset managers, however, the most significant update is that the CFTC declined to adopt the proposed minimum disclosure requirements. Under existing Regulation 4.7, CPOs and CTAs are exempt from certain disclosure requirements when offering pools solely to QEPs. Without those exemptions, dually-registered managers would be burdened with duplicate or conflicting disclosure requirements under the Securities and Exchange Commission’s (SEC) rules. The Proposed Rule would have rescinded or narrowed certain of these exemptions. Commenters almost unanimously opposed the disclosure-related amendments, and the CFTC ultimately decided to take additional time to consider the concerns and potential alternatives.

The Final Rule doubled the Portfolio Requirement for the Securities Portfolio Test and the Initial Margin and Premium test to US$4,000,000 and US$400,000, respectively. Despite the increased suitability standards for QEPs, the Final Rule will not impact most private funds relying on Rule 506 of Regulation D, as those amounts are still less than the “Qualified Purchaser” threshold under the SEC’s rules.

Poor Oversight: Healthcare Company & Owner to Pay $1 Million for Care Plan Oversight Service Billing Fraud

The United States announced that Chicago-based healthcare company Apollo Health Inc. (Apollo), and its owner, Brian J. Weinstein, will pay $1 million to resolve False Claims Act allegations. The claims state that Apollo, under the direction of Weinstein, submitted bills to Medicare for services that were never performed. The case was brought by two whistleblowers who will be rewarded for their efforts.

From December 2014 through March 2017, Apollo allegedly submitted Medicare claims for care plan oversight services (CPO) that did not occur. CPOs detail a physician’s duties to supervise a patient receiving complex medical care. Weinstein allegedly directed Apollo to submit 12,592 CPO service claims for over two dozen providers employed by Apollo, despite Weinstein’s knowledge that no services had been rendered to Medicare patients, and no CPO services were documented in medical records.
Medicare fraud undermines the trust and integrity of the healthcare system, resulting in significant financial burdens on taxpayers. When individuals or organizations engage in fraudulent activities, such as billing for services not rendered or submitting false claims, they siphon funds from Medicare’s intended beneficiaries. Medicare fraud diminishes the resources available for legitimate healthcare services for truly ill Medicare beneficiaries.
The settlement resolves claims brought by two whistleblowers, also known as relators, under the qui tam provisions of the False Claims Act. Javar Jones and Louis Curet, the relators in the case, will receive 20% of the settlement amount for bringing the fraudulent activity to the United States’ attention. Whistleblowers who report fraud against the government via a qui tam lawsuit can earn a 15-25% share of the government’s recovery.